ArticleJournal of molecular histology2025

Study on the mechanism of costunolide inhibiting triple-negative breast cancer by EGFR ubiquitination and degradation to suppress the ERK/AKT signaling pathway.

Ying Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.